Breaking

Starbucks union votes to authorize strike ahead of last scheduled bargaining session in 2024
Massie drops colorful analogy opposing foreign aid, mocks Speaker Johnson with AI-generated image
New national poll reveals approval ratings for Biden, Trump amidst transition
France’s Mayotte cleans up after cyclone, total death toll still unknown
Opawica Explorations: Advancing High-potential Gold Assets in the Prolific Abitibi Greenstone Belt
Opawica Explorations: Advancing High-potential Gold Assets in the Prolific Abitibi Greenstone Belt
E-Power Resources Inc. Announces Flow-Through Private Placement
The Assad regime has fallen. Why are foreign powers still targeting Syria?

Politics
Business
World
Investing
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Opawica Explorations: Advancing High-potential Gold Assets in the Prolific Abitibi Greenstone Belt

December 18, 2024

Opawica Explorations: Advancing High-potential Gold Assets in the Prolific Abitibi Greenstone Belt

December 18, 2024

E-Power Resources Inc. Announces Flow-Through Private Placement

December 18, 2024

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,331)
- Investing (3,440)
- Politics (5,097)
- World (4,569)

Disclaimer: payfordesire.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2024 payfordesire.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.